Here’s our take on the landmark Amgen case now before the Supreme Court. This Forbes.com article looks at why the issues are so important for business, the grim economic impact of a negative ruling, and, less obviously, the dangers of a positive ruling if corporations are then encouraged to cut a few corners in how they communicate with investors and other stakeholders.  
 
Read More